buyers v sellers, page-42

Everyone please remember the primary goal of a phase I trial is to evaluate the safety of the vaccine before increasing participants, the secondary goal is to see if the vaccine generates an immune response. The interim results have already said they are safe and that there is a T-cell response. They are yet to state what T-cell response was achieved but I highly doubt that they will care to even speculate on robustness of response or longevity. That type of information is far more typical from a phase II or III trial. In addition, it has already been stated that the interim results are enough to go off to start to plan the phase II trials. Data analysis takes time and can’t be rushed through so be patient and the results will come.

As always, do your own research.